Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of ColoSense®, the only RNA-based at-home test for colorectal ...

An at-home FIT test is a screening tool that may detect colon cancer. It works by testing for blood in the stool, which can be an early sign of colon cancer caused by colorectal polyps that leak blood ...

Collaborative trial with Alliance for Clinical Trials in Oncology will evaluate new approaches to increase germline genetic testing among at-risk family members Research will also assess the clinical ...

Regular preventive screenings can make a life-changing difference—especially when it comes to cancer. According to the American Cancer Society, colorectal cancer is the third-leading cause of ...

Labcorp has collaborated with the Alliance for Clinical Trials in Oncology on a new study that seeks to expand access to genetic testing among patients newly diagnosed with colorectal cancer (CRC) and ...

A large trial in US community health centers shows mailed FIT-DNA kits outperform FIT in boosting colorectal cancer screening. Despite this, fewer than 4 in 10 patients with abnormal results complete ...

New pharmacogenomic test detects all DPYD variants recommended by the Association for Molecular Pathology to support safer, more personalized cancer treatment BURLINGTON, N.C., May 28, 2026 ...